FSH Fisher Scientific

Fisher Scientific International Inc. (NYSE: FSH) announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device conference on Feb. 9 at 11:40 a.m. Eastern Standard Time (EST) at the Grand Hyatt Hotel in New York City. Access to the webcast of the presentation and the presentation slides will be available on the company's Web site at www.fisherscientific.com on the day of the conference and will be archived until March 1. Fisher Scientific: A World Leader in Serving Science Fisher Scientific International Inc. (NYSE: FSH) is a leading provider of products and services to the scientific community. Fisher facilitates discovery by supplying researchers and clinicians in labs around the world with the tools they need. We serve pharmaceutical and biotech companies; colleges and universities; medical-research institutions; hospitals; reference, quality-control, process-control and R&D labs in various industries; as well as government agencies. From biochemicals, cell-culture media and proprietary RNAi technology to rapid-diagnostic tests, safety products and other consumable supplies, Fisher provides more than 600,000 products and services. This broad offering, combined with Fisher's globally integrated supply chain and unmatched sales and marketing presence, helps make our 350,000 customers more efficient and effective at what they do. Founded in 1902, Fisher Scientific is a FORTUNE 500 company and is a component of the S&P 500 Index. Fisher Scientific is a company committed to high standards and delivering on our promises -- to customers, shareholders and employees alike. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com.